A phase 2 multicenter trial of ruxolitinib to treat bronchiolitis obliterans syndrome after allogeneic HCT
Autor: | DeFilipp, Zachariah, Kim, Haesook T., Cheng, Guang-Shing, Hamilton, Betty K., Chhabra, Saurabh, Hamadani, Mehdi, Sandhu, Karamjeet S., Perez, Lia, Lee, Catherine J., Brennan, Timothy L., Garrelts, Cassandra, Brown, Bergin M., Gallagher, Kathleen, Newcomb, Richard A., El-Jawahri, Areej, Chen, Yi-Bin |
---|---|
Zdroj: | In Blood Advances September 2024 |
Databáze: | ScienceDirect |
Externí odkaz: |